Aeglea BioTherapeutics
cystinuria patient needs not adequately addressed | Aeglea BioTherapeutics
Company
Deck Type
Sector
Industry
Deck date
August 2020
Slide
25 of 28
Related slides by other companies
Nuvectis Pharma
Investor Presentation
August 2023
phase underway fast track designation | Nuvectis Pharma
Nuvectis Pharma
Investor Presentation
January 2024
phase underway fast track designation | Nuvectis Pharma
Spotify
Results
April 2023
key highlights record high mau growth of million net additions revenue growth and gross margin multiple updates to the experience unveiled at stream on | Spotify
ATAI
Investor Presentation
October 2023
product overview for depression | ATAI
Other recent decks by Aeglea BioTherapeutics
See all presentations (14 decks)
Investor Presentation
October 2023
Investor Presentation
October 2023
Investor Presentation
September 2023
Investor Presentation
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io